NYU Langone researchers propose new model for cancer drug resistance
NYU Langone Health researchers have proposed a new explanation for how cancer cells develop drug resistance by adapting through protein mechanisms rather than permanent genetic changes. Their findings highlight potential new targets for therapy aimed at preventing tumors from becoming resistant.









